AKBA · Akebia Therapeutics, Inc. · Debt
$0.87
-0.01 (-0.69%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$244.05M
Shares
277.11M
Volume · Oct 2
7.11M
Avg daily vol (3M)
6.07M
Debt Profile
Annual debt figures are established from annual reports and updated by subsequent interim reports and event disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Reported debt balances
Balances may overlap and are not added together. Each row keeps its reported scope and date.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 1,006,000 | 10-Q filed 2026-08-05 |
| Current portion of long-term debt | 2026-06-30 | USD 24,809,000 | 10-Q filed 2026-08-05 |
| Long-term debt | 2026-06-30 | USD 49,563,000 | 10-Q filed 2026-08-05 |
| Noncurrent long-term debt | 2026-06-30 | USD 24,754,000 | 10-Q filed 2026-08-05 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 4,400,000 | 10-Q filed 2026-08-05 |
| Operating lease liabilities | 2026-06-30 | USD 5,338,000 | 10-Q filed 2026-08-05 |
Debt data is being processed. Please check back later.